Melanoma biology and new targeted therapy

被引：1078

作者：

Gray-Schopfer, Vanessa ^{[1
]}

Wellbrock, Claudia ^{[1
]}

Marais, Richard ^{[1
]}

机构：

[1] Canc Res UK, Inst Canc Res, Signal Transduct Team, Ctr Cell & Mol Biol, London SW3 6JB, England

来源：

NATURE | 2007年 / 445卷 / 7130期

关键词：

D O I：

10.1038/nature05661

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Melanoma is a cancer that arises from melanocytes, specialized pigmented cells that are found predominantly in the skin. The incidence of melanoma is rising steadily in western populations - the number of cases worldwide has doubled in the past 20 years. In its early stages malignant melanoma can be cured by surgical resection, but once it has progressed to the metastatic stage it is extremely difficult to treat and does not respond to current therapies. Recent discoveries in cell signalling have provided greater understanding of the biology that underlies melanoma, and these advances are being exploited to provide targeted drugs and new therapeutic approaches.

引用

页码：851 / 857

页数：7

共 101 条

[11] The role of Bcl-2 family members in the progression of cutaneous melanoma [J].

Bush, JA ;

Li, G .

CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (06) :531-539

[12]

Chen DH, 2003, CANCER RES, V63, P6626

[13] Essential role for oncogenic Ras in tumour maintenance [J].

Chin, L ;

Tam, A ;

Pomerantz, J ;

Wong, M ;

Holash, J ;

Bardeesy, N ;

Shen, Q ;

O'Hagan, R ;

Pantginis, J ;

Zhou, H ;

Horner, JW ;

Cordon-Cardo, C ;

Yancopoulos, GD ;

DePinho, RA .

NATURE, 1999, 400 (6743) :468-472

[14] A STUDY OF TUMOR PROGRESSION - THE PRECURSOR LESIONS OF SUPERFICIAL SPREADING AND NODULAR MELANOMA [J].

CLARK, WH ;

ELDER, DE ;

GUERRY, D ;

EPSTEIN, MN ;

GREENE, MH ;

VANHORN, M .

HUMAN PATHOLOGY, 1984, 15 (12) :1147-1165

[15]

Cohen C, 2002, CLIN CANCER RES, V8, P3728

[16]

Collisson EA, 2003, CANCER RES, V63, P5669

[17] Cutaneous malignant melanoma [J].

Cummins, DL ;

Cummins, JM ;

Pantle, H ;

Silverman, MA ;

Leonard, AL ;

Chanmugam, A .

MAYO CLINIC PROCEEDINGS, 2006, 81 (04) :500-507

[18] Distinct sets of genetic alterations in melanoma [J].

Curtin, JA ;

Fridlyand, J ;

Kageshita, T ;

Patel, HN ;

Busam, KJ ;

Kutzner, H ;

Cho, KH ;

Aiba, S ;

Bröcker, EB ;

LeBoit, PE ;

Pinkel, D ;

Bastian, BC .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2135-2147

[19] Therapeutic targets - MTOR and related pathways [J].

Dancey, Janet E. .

CANCER BIOLOGY & THERAPY, 2006, 5 (09) :1065-1073

[20] Mutations of the BRAF gene in human cancer [J].

Davies, H ;

Bignell, GR ;

Cox, C ;

Stephens, P ;

Edkins, S ;

Clegg, S ;

Teague, J ;

Woffendin, H ;

Garnett, MJ ;

Bottomley, W ;

Davis, N ;

Dicks, N ;

Ewing, R ;

Floyd, Y ;

Gray, K ;

Hall, S ;

Hawes, R ;

Hughes, J ;

Kosmidou, V ;

Menzies, A ;

Mould, C ;

Parker, A ;

Stevens, C ;

Watt, S ;

Hooper, S ;

Wilson, R ;

Jayatilake, H ;

Gusterson, BA ;

Cooper, C ;

Shipley, J ;

Hargrave, D ;

Pritchard-Jones, K ;

Maitland, N ;

Chenevix-Trench, G ;

Riggins, GJ ;

Bigner, DD ;

Palmieri, G ;

Cossu, A ;

Flanagan, A ;

Nicholson, A ;

Ho, JWC ;

Leung, SY ;

Yuen, ST ;

Weber, BL ;

Siegler, HF ;

Darrow, TL ;

Paterson, H ;

Marais, R ;

Marshall, CJ ;

Wooster, R .

NATURE, 2002, 417 (6892) :949-954

← 1 2 3 4 5 6 7 8 9 10 →